Advances in and the Applicability of Machine Learning-Based Screening and Early Detection Approaches for Cancer: A Primer

Deep transfer learning for IDC breast cancer detection using fast AI technique and Sqeezenet architecture

One of the most effective approaches for identifying breast cancer is histology, which is the meticulous inspection of tissues under a microscope. The kind of cancer cells, or whether they are cancerous (malignant) or non-cancerous, is typically determined by the type of tissue that is analyzed by the test performed by the technician (benign). The goal of this study was to automate IDC classification within breast cancer histology samples using a transfer learning technique. To improve our outcomes, we combined a Gradient Color Activation Mapping (Grad CAM) and image coloring mechanism with a discriminative fine-tuning methodology employing a one-cycle strategy using FastAI techniques. There have been lots of research studies related to deep transfer learning which use the same mechanism, but this report uses a transfer learning mechanism based on lightweight Squeeze Net architecture, a variant of CNN (Convolution neural network). This strategy demonstrates that fine-tuning on Squeeze Net makes it possible to achieve satisfactory results when transitioning generic features from natural images to medical images.

Artificial Intelligence in Oncology: A Topical Collection in 2022

Artificial intelligence (AI) is considered one of the core technologies of the Fourth Industrial Revolution that is currently taking place [...].

A Series-Based Deep Learning Approach to Lung Nodule Image Classification

Although many studies have shown that deep learning approaches yield better results than traditional methods based on manual features, CADs methods still have several limitations. These are due to the diversity in imaging modalities and clinical pathologies. This diversity creates difficulties because of variation and similarities between classes. In this context, the new approach from our study is a hybrid method that performs classifications using both medical image analysis and radial scanning series features. Hence, the areas of interest obtained from images are subjected to a radial scan, with their centers as poles, in order to obtain series. A U-shape convolutional neural network model is then used for the 4D data classification problem. We therefore present a novel approach to the classification of 4D data obtained from lung nodule images. With radial scanning, the eigenvalue of nodule images is captured, and a powerful classification is performed. According to our results, an accuracy of 92.84% was obtained and much more efficient classification scores resulted as compared to recent classifiers.

Ageing and cancer: a research gap to fill

The complex mechanisms of ageing biology are increasingly understood. Interventions to reduce or delay ageing‐associated diseases are emerging. Cancer is one of the diseases promoted by tissue ageing. A clockwise mutational signature is identified in many tumours. Ageing might be a modifiable cancer risk factor. To reduce the incidence of ageing‐related cancer and to detect the disease at earlier stages, we need to understand better the links between ageing and tumours. When a cancer is established, geriatric assessment and measures of biological age might help to generate evidence‐based therapeutic recommendations. In this approach, patients and caregivers would include the respective weight to give to the quality of life and survival in the therapeutic choices. The increasing burden of cancer in older patients requires new generations of researchers and geriatric oncologists to be trained, to properly address disease complexity in a multidisciplinary manner, and to reduce health inequities in this population of patients. In this review, we propose a series of research challenges to tackle in the next few years to better prevent, detect and treat cancer in older patients while preserving their quality of life.

System for the Recognizing of Pigmented Skin Lesions with Fusion and Analysis of Heterogeneous Data Based on a Multimodal Neural Network

Simple Summary

Skin cancer is one of the most common cancers in humans. This study aims to create a system for recognizing pigmented skin lesions by analyzing heterogeneous data based on a multimodal neural network. Fusing patient statistics and multidimensional visual data allows for finding additional links between dermoscopic images and medical diagnostic results, significantly improving neural network classification accuracy. The use by specialists of the proposed system of neural network recognition of pigmented skin lesions will enhance the efficiency of diagnosis compared to visual diagnostic methods.

Abstract

Today, skin cancer is one of the most common malignant neoplasms in the human body. Diagnosis of pigmented lesions is challenging even for experienced dermatologists due to the wide range of morphological manifestations. Artificial intelligence technologies are capable of equaling and even surpassing the capabilities of a dermatologist in terms of efficiency. The main problem of implementing intellectual analysis systems is low accuracy. One of the possible ways to increase this indicator is using stages of preliminary processing of visual data and the use of heterogeneous data. The article proposes a multimodal neural network system for identifying pigmented skin lesions with a preliminary identification, and removing hair from dermatoscopic images. The novelty of the proposed system lies in the joint use of the stage of preliminary cleaning of hair structures and a multimodal neural network system for the analysis of heterogeneous data. The accuracy of pigmented skin lesions recognition in 10 diagnostically significant categories in the proposed system was 83.6%. The use of the proposed system by dermatologists as an auxiliary diagnostic method will minimize the impact of the human factor, assist in making medical decisions, and expand the possibilities of early detection of skin cancer.

Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients

BACKGROUND AND AIM

Available evidence suggests elevated serum prolactin (PRL) levels in olanzapine (OLZ)-treated patients with schizophrenia. However, machine learning (ML)-based comprehensive evaluations of the influence of pathophysiological and pharmacological factors on PRL levels in OLZ-treated patients are rare. We aimed to forecast the PRL level in OLZ-treated patients and mine pharmacovigilance information on PRL-related adverse events by integrating ML and electronic health record (EHR) data.

METHODS

Data were extracted from an EHR system to construct an ML dataset in 672×384 matrix format after preprocessing, which was subsequently randomly divided into a derivation cohort for model development and a validation cohort for model validation (8:2). The eXtreme gradient boosting (XGBoost) algorithm was used to build the ML models, the importance of the features and predictive behaviors of which were illustrated by SHapley Additive exPlanations (SHAP)-based analyses. The sequential forward feature selection approach was used to generate the optimal feature subset. The co-administered drugs that might have influenced PRL levels during OLZ treatment as identified by SHAP analyses were then compared with evidence from disproportionality analyses by using OpenVigil FDA.

RESULTS

The 15 features that made the greatest contributions, as ranked by the mean (|SHAP value|), were identified as the optimal feature subset. The features were gender_male, co-administration of risperidone, age, co-administration of aripiprazole, concentration of aripiprazole, concentration of OLZ, progesterone, co-administration of sulpiride, creatine kinase, serum sodium, serum phosphorus, testosterone, platelet distribution width, α-L-fucosidase, and lipoprotein (a). The XGBoost model after feature selection delivered good performance on the validation cohort with a mean absolute error of 0.046, mean squared error of 0.0036, root-mean-squared error of 0.060, and mean relative error of 11%. Risperidone and aripiprazole exhibited the strongest associations with hyperprolactinemia and decreased blood PRL according to the disproportionality analyses, and both were identified as co-administered drugs that influenced PRL levels during OLZ treatment by SHAP analyses.

CONCLUSIONS

Multiple pathophysiological and pharmacological confounders influence PRL levels associated with effective treatment and PRL-related side-effects in OLZ-treated patients. Our study highlights the feasibility of integration of ML and EHR data to facilitate the detection of PRL levels and pharmacovigilance signals in OLZ-treated patients.